Update in “The Sticky Cholesterol”: Lipoprotein(a) AKA Lp(a), Bob Harper, and Your Risk of Disease

If lipoprotein(a) was a stock, it would be time to invest. The interest is growing and growing.

The cynic would say that this is because an agent is in trials and the money for pharmacological therapy of this “sticky cholesterol”, also known as L(a), pronounced LP little a, will be flowing soon. The kind hearted would say that it is just the normal evolution of medical knowledge. I have written before about the high-profile health issues of one of the Biggest Loser…

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Joel Kahn

Professor of Cardiology, Summa cum Laude grad, Kahn Center for Longevity and GreenSpace Cafe. www.drjoelkahn.com @drjkahn. Author The Plant Based Solution NEW